Cardiovascular medicine Onglyza
La merchandise du producteur
Disponible
Précisez un prix auprès du vendeur
- Customer pickup,
- Courier
- En details
Le vendeur
Belgique, Bruxelles
(Afficher sur la carte)
(Afficher sur la carte)
+32(
Afficher les numéros de téléphone
Produits d'autres entreprises
la description
ONGLYZA™ is a treatment for patients with type 2 diabetes that has been
developed by an alliance between AstraZeneca and Bristol-Myers Squibb.
ONGLYZA is one of a class of compounds called DPP-4 inhibitors - known as gliptins - that work by enhancing the action of natural hormones in the body called incretins. Incretins decrease elevated blood sugar levels (glucose) by increasing the body's utilization of sugar, mainly through increasing insulin secretion from the pancreas, and by reducing the liver's production of glucose.
Contact the seller
Cardiovascular medicine Onglyza
We recommend to see